Brussels, May 14, 2019 --- Solvay today held its General Shareholders’ Meeting at The Square – Brussels Meeting Center. 

Shareholders voted in favor of all the resolutions proposed. More specifically, they approved the payment of a gross dividend of € 3.75 per share for the year 2018. After deduction of the interim dividend of € 1.44 gross per share, paid in January 2019, the balance amounts to € 2.31 gross per share, payable as of May 23, 2019. 

During the General Shareholders Meeting, shareholders also approved the re-election of Mrs. Marjan Oudeman as independent director and Mr. Charles Casimir-Lambert as director of the Board, both for a four-year term. The shareholders also confirmed the mandate of Mrs. Ilham Kadri as director. Mr. Yves-Thibault de Silguy has reached the statutory age limit and therefore did not seek re-appointment. The number of directors therefore falls from 16 to 15.

The Board has unanimously decided to appoint Mrs. Amparo Moraleda to chair the Nominations Committee, succeeding to Mr. Yves-Thibault de Silguy.

Details of the resolutions and voting results as well as a replay of the shareholder meeting are available on Solvay’s website, Investors section.

FOLLOW US ON TWITTER @SOLVAYGROUP

Solvay is an advanced materials and specialty chemicals company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers worldwide in many diverse end-markets. Its products are used in planes, cars, batteries, smart and medical devices, as well as in mineral and oil and gas extraction, enhancing efficiency and sustainability. Its lightweighting materials promote cleaner mobility, its formulations optimize the use of resources, and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 24,500 employees in 62 countries. Net sales were €10.3 billion in 2018, with 90% from activities where Solvay ranks among the world’s top 3 leaders, resulting in an EBITDA margin of 22%. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY), are traded through a level-1 ADR program. (Financial figures take into account the planned divestment of Polyamides).